Metabolic and endocrine diseases, cartilage calcification and arthritis

Current Opinion in Rheumatology

Volumn 25, Issue 2, 2013, Pages 198-203

  Taylor, Adam M ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

alkaptonuria; arthritis; cartilage calcification; crystal

Indexed keywords

CALCIUM ION; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; GROWTH HORMONE; PROTEOGLYCAN; PYROPHOSPHATASE PHOSOPHODIESTERASE 1; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ACROMEGALY; AGING; ARTERY CALCIFICATION; ARTHRITIS; ARTICULAR CARTILAGE; AUTOSOMAL RECESSIVE DISORDER; CHONDROCALCINOSIS; COLLAGEN SYNTHESIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENDOCRINE DISEASE; ENZYME DEFICIENCY; EXTRACELLULAR MATRIX; GENETIC PREDISPOSITION; GROWTH PLATE; HYPOPHOSPHATASIA; HYPOPHYSIS ADENOMA; KEUTEL SYNDROME; METABOLIC DISORDER; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SUBCHONDRAL BONE PLATE; WNT SIGNALING PATHWAY;

ANIMALS; CALCINOSIS; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; ENDOCRINE SYSTEM DISEASES; HUMANS; METABOLIC DISEASES; MICE; OSTEOARTHRITIS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84873408497     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835d8ff8     Document Type: Review

References (46)

1. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012; 64:1697-1707.
2. Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 2010; 26:371-386.
3. Ea HK, Nguyen C, Bazin D, et al. Articular cartilage calcification in osteoarthritis: insights into crystal-induced stress. Arthritis Rheum 2011; 63:10-18.
4. Ferguson VL, Bushby AJ, Boyde A. Nanomechanical properties and mineral concentration in articular calcified cartilage and subchondral bone. J Anat 2003; 203:191-202.
5. Ea HK, Liote F. Advances in understanding calcium-containing crystal disease. Curr Opin Rheumatol 2009; 21:150-157.
6. Terkeltaub RA. What does cartilage calcification tell us about osteoarthritis? J Rheumatol 2002; 29:411-415.
7. Chen CC, Boskey AL, Rosenberg LC. The inhibitory effect of cartilage proteoglycans on hydroxyapatite growth. Calcif Tissue Int 1984; 36:285-290.
8. Heinegard D, Bayliss B, Lorenzo P. Articular cartilage: biochemistry and metabolism of normal and osteoarthritic cartilage. In: Brandt K, Doherty M, Lohmander L, editors. Osteoarthritis, 2nd ed. Oxford: Oxford University Press; 2003. pp. 73-82.
9. Shakabei M, Abour-Rebyeh H, Merker HJ. Integrins in aging cartilagetissue in vitro. Histol Histopathol 1993; 8:715-723.
10. Catterall JB, Hsueh MF, Stabler TV, et al. Protein modification by deamidation indicates variations in joint extracellular matrix turnover. J Biol Chem 2012; 287:4640-4651.
11. Von derMark K, Kirsch T, Nerlich A, et al. Type Xcollagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 1992; 35:806-811.
12. De Luca F, Barnes KM, Uyeda JA, et al. Regulation of growth plate chon-drogenesis by bone morphogenetic protein-2. Endocrinology 2001; 142: 430-436.
13. Anderson HC. Matrix vesicles and calcification. Curr Rheumatol Rep 2003; 5:222-226.
14. Anderson HC. Electron microscopic studies of induced cartilage develop-ment and calcification. J Cell Biol 1967; 35:81-101.
15. Bonucci E. Fine structure of early cartilage calcification. J Ultrastruct Res 1967; 20:33-50.
16. Kirsch T, Harrison G, Golub EE, Nah HD. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of the growth plate cartilage. J Biol Chem 2000; 275:35577-35583.
17. Kirsch T, Swoboda B, Nah H. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000; 8:294-302.
18. Montessuit C, Caverzasio J, Bonjour JP. Characterization of a Pi transport system in cartilage matrix vesicles. Potential role in the calcification process. J Biol Chem 1991; 266:17791-17797.
19. Golub EE. Biomineralization and matrix vesicles in biology and pathology. Semin Immunopathol 2011; 33:409-417.
20. Grskovic I, Kutsch A, Frie C, et al. Depletion of annexin A5, annexin A6 and collagen X causes no gross changes in matrix vesicle mediated mineralization, but lack of collagen X affects hematopoiesis and the Th1/Th2 response. J Bone Miner Res 2012; 27:2399-2412.
21. Hessle L, Johnson KA, Anderson HC, et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antag-onistic regulators of bone mineralization. Proc Natl Acad Sci USA 2002; 99:9445-9449.
22. Terkeltaub R, Rosenbach M, Fong F, Goding J. Causal link between nucleo-tide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibro-blasts and osteoblasts with plasma cell membrane glycoprotein-1: relevance to calcium pyrophosphate dihydrate deposition disease. Arthritis Rheum 1994; 37:934-941.
23. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000; 289:265-270.
24. Johnson K, Hashimoto S, Lotz M, et al. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 2001; 44:1071-1081.
25. Reibel A, Manière MC, Clauss F, et al. Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis 2009; 4:6.
26. Pendleton A, Johnson MD, Hughes A, et al. Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet 2002; 71:933-940.
27. Rutsch F, Ruf N, Vaingankar S, et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 2003; 34:379-381.
28. Rutsch F, Vaingankar S, Johnson K, et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 2001; 158:543-554.
29. Bertrand J, Nitschke Y, Fuerst M, et al. Decreased levels of nucleotide pyrophosphatase phosphodiesterase 1 are associated with cartilage calci-fication in osteoarthritis and trigger osteoarthritic changes in mice. Ann Rheum Dis 2012; 71:1249-1253.
30. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386:78-81.
31. Munroe PB, Olgunturk RO, Fryns JP, et al. Mutations in thegeneencoding the human matrixGlaprotein cause Keutel syndrome. Nat Genet 1999; 21:142-144.
32. O'Young J, Liao Y, Xiao Y, et al. Matrix Glaprotein inhibitsectopiccalcification by a direct interaction with hydroxyapatite crystals. Am Chem Soc. 2011; 133:18406-18412.
33. Nishimura R, Wakabayashi M, Hata K, et al. Osterixregulatescalcification and degradation of chondrogenic matrices through Matrix Metalloproteinase (MMP13) expression in association with transcription factor Runx2 during endochondral ossification. J Biol Chem 2012; 287:33179-33190.
34. Nguyen C, Lieberherr M, Bordat C, et al. Intracellular calcium oscillations in articular chondrocytes induced by basic calcium phosphate crystals lead to cartilage degradation. Osteoarthritis Cartilage 2012; 20:1399-1408.
35. Boyde A, Riggs CM, Bushby AJ, et al. Cartilage damage involving extrusion of mineralisable matrix from the articular calcified cartilage and subchondral bone. Eur Cell Mater 2011; 21:470-478.
36. Rosenthal AK. Crystals, inflammation, and osteoarthritis. Curr Opin Rheuma-tol 2011; 23:170-173.
37. Denoble AE, Huffman KM, Stabler TV, et al. Uric acid is a danger signal of increasing riskfor osteoarthritis through inflammasome activation. Proc Natl Acad Sci USA 2011; 108:2088-2093.
38. Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237-241.
39. Moester MJC, Papapoulos SE, Löwik CWGM, van Bezooijen RL. Sclerostin: current knowledge and future perspectives. Calcif Tissue Int 2010; 87:99-107.
40. Taylor AM, Wlodarski B, Prior IA, et al. Ultrastructural examination oftissue in a patient with alkaptonuric arthropathy reveals a distinct pattern of binding of ochronotic pigment. Rheumatology (Oxford) 2010; 49:1412-1414.
41. Taylor AM, Boyde A, Wilson PJ, et al. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum 2011; 63:3887-3896.
42. Taylor AM, Boyde A, Davidson JS, et al. Identification of trabecular excres-cences, novel microanatomical structures, present in bone in osteoarthro-pathies. Eur Cell Mater 2012; 23:300-309.
43. Sahinbegovic E, Dallos T, Aigner E, et al. Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum 2010; 62:3792-3798.
44. Richette P, Ottaviani S, Vicaut E, Bardin T. Musculoskeletal complications of hereditary hemochromatosis: a case-control study. J Rheumatol 2010; 37:2145-2150.
45. Ohno T, Hashimoto N, Mitsui K, et al. Iron overload inhibits calcification and differentiation of ATDC5 cells. J Biochem 2012; 151:109-114.
46. Chen-An P, Andreassen KV, Henriksen K, et al. Investigation of chondrocyte hypertrophy and cartilage calcification in a full-depth articular cartilage explants model. Rheumatol Int 2012. [Epub ahead of print]